News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Akhil Santhosh: Strategies to improve beyond KATHERINE
Akhil Santhosh
May 9, 2025, 15:40

Akhil Santhosh: Strategies to improve beyond KATHERINE

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on X:

“Strategies to improve beyond KATHERINE
1. ASTEFANIA: TDM1+/-Atezolizumab
2. COMPASS HER2 RD: TDM1+/-Tucatinib
3. Destiny breast 05: TDM1 vs TdXD “

KATHERINE

More posts featuring Akhil Santhosh

Akhil Santhosh Breast Cancer cancer KATHERINE OncoDaily Oncology
Special Coverage
Blog
Jul 18, 2025, 19:04
"Belantamab Mafodotin Gives Patients a Chance" Says Diane Moran - International Myeloma Foundation
Insight
Jul 18, 2025, 18:53
Raffaele Colombo: International Nonproprietary Names Proposed List 133 Is Out
Insight
Jul 18, 2025, 18:46
Akhil Santhosh: OrigAMI1 - The Effect of Amivantamab in Previously Treated RAS Wild Colon Cancer
Blog
Jul 18, 2025, 18:33
Herbert Loong: Thrilled to Welcome My "Partner-in-Crime" to the Chinese University of Hong Kong
Blog
Jul 18, 2025, 18:18
The WHO Global Cancer Experience Survey Is Open - Childhood Cancer International
Blog
Jul 18, 2025, 18:08
Christine Regan: How to Bridge Gaps in the Fight Against Cancer?
Insight
Jul 18, 2025, 18:06
Muhammad Umair Mushtaq: Impact of Body Mass Index on Outcomes Following Allo-HSCT
Blog
Jul 18, 2025, 17:51
Vital Importance of Biomedical Research - American Association for Cancer Research
Opinion
Jul 18, 2025, 17:51
Rahul Banerjee: I Have Immense Faith in Oncologists’ Abilities to De-Escalate Bela-Maf
Insight
Jul 18, 2025, 17:19
Mohamad Mohty: DREAMM-7 Marks a Step Forward in Relapsed Myeloma
Blog
Jul 18, 2025, 17:06
The Full List of Potential dGOF Projects was Ordered for Pause - National Institutes of Health
Blog
Jul 18, 2025, 17:01
Amol Akhade: Want to Raise a Critical Point on a Published Clinical Trial?